Quidelortho Quote - 0A55 | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
UK
LSE
Quidelortho Corp (0A55) Share Price

Quidelortho Corp (0A55)

0.00

0.00

(0.00%)

Closed 31 January 3:30AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

-

Bid

0.00

Offer

0.00

Volume

7

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

66,819,000

Dividend Yield

-

PE Ratio

-287.83

Earnings Per Share (EPS)

-0.15

Revenue

3B

Net Profit

-10.1M

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

/www.quidelortho.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Quidelortho Corp is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker 0A55. The last closing price for Quidelortho was US$0. Over the last year, Quidelortho shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Quidelortho currently has 66,819,000 shares in issue. Quidelortho has a price to earnings ratio (PE ratio) of -287.83.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0A55 - Frequently Asked Questions (FAQ)

What is the current Quidelortho share price?

The current share price of Quidelortho is US$ 0.00

How many Quidelortho shares are in issue?

Quidelortho has 66,819,000 shares in issue

What is the 1 year trading range for Quidelortho share price?

Quidelortho has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Quidelortho?

The price to earnings ratio of Quidelortho is -287.83

What is the cash to sales ratio of Quidelortho?

The cash to sales ratio of Quidelortho is 0.97

What is the reporting currency for Quidelortho?

Quidelortho reports financial results in USD

What is the latest annual turnover for Quidelortho?

The latest annual turnover of Quidelortho is USD 3B

What is the latest annual profit for Quidelortho?

The latest annual profit of Quidelortho is USD -10.1M

What is the registered address of Quidelortho?

The registered address for Quidelortho is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Quidelortho website address?

The website address for Quidelortho is /www.quidelortho.com

Which industry sector does Quidelortho operate in?

Quidelortho operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GILDGuild Esports Plc	0.075p (66.67%)	158.2M
MSMNMosman Oil And Gas Limited	0.038p (52.00%)	2.3B
MODER8 Capital Investments Plc	2.10p (40.00%)	7.75M
LENDSancus Lending Group Limited	0.60p (33.33%)	2.2M
KMKKromek Group Plc	6.65p (25.47%)	41.88M
FUMFutura Medical Plc	16.98p (-45.23%)	8.72M
RCDORicardo Plc	263.00p (-25.28%)	4.42M
PEGPetards Group Plc	6.50p (-18.75%)	1.16M
SCGLSealand Capital Galaxy Limited	6.50p (-14.47%)	6.21M
SIVSivota Plc	3.00p (-14.29%)	7.5k
MSMNMosman Oil And Gas Limited	0.038p (52.00%)	2.3B
DKEDukemount Capital Plc	0.055p (22.22%)	1.4B
EMEEmpyrean Energy Plc	0.115p (4.55%)	917.03M
TRPTower Resources Plc	0.0295p (3.51%)	470.89M
DGIDg Innovate Plc	0.0155p (-8.82%)	344.08M

stockinspector

stockinspector 34 seconds ago

Volume today so far 9.17M
Avg Vol (30) 7.61M

trader53

trader53 38 seconds ago

DPLS CEO "We will make the Note Payment Early"

DPLS 0.0004 - Short Squeeze Soon!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175735249

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
__________________

Jimmy Joe

Jimmy Joe 43 seconds ago

You just don't get it.

Cardmaster, Jet gets it. His nonsense is just a cover for years of attacking this ticker, $DBMM.

He/she knows time is almost up. Continued howling at the moon is the "uniformed" cover. It won't work, it won't stick.

Just my opinion

docj

docj 44 seconds ago

Guess who gets a mention? Thanks brentie!

3.1. Mononclonal Antibodies

"Leronlimab is currently in phase III clinical trials for preventing HIV infection [308], but has previously shown promise in treating breast cancer. In triple negative breast cancer lines, Leronlimab

RobotDroid

RobotDroid 50 seconds ago

You invested in the worlds worst ceo, a mute inept grifter.

Bizreader

Bizreader 51 seconds ago

I'm just going to call you a whack job because using the word truth is not true you know prove it and to confront me on the truth is just a trouble making idea. And yeah I'll be here on the 4th and you can tell me what truth you told me that relates to the 4th. I mean you better you know Tell me wha

Mark

Mark 1 minute ago

$CASK 1.39 back to highs

The ELTP King

The ELTP King 1 minute ago

Well golly gee whiz...

I thought the stock was going to go down EVERYDAY for the rest of our lives.

Are you a high school DROPOUT?

Why are we up today?

saj

saj 1 minute ago

I have not played it a friend came over probably saved me $$

gdog

gdog 1 minute ago

1-30 B EIX $53.55

monchichi

monchichi 2 minutes ago

I'm just anxious for the 7th to get here :)

OMOLIVES

OMOLIVES 2 minutes ago

More to show tonight...time to start pulling out the book marks. Ybyra has been in disarray sine April 2024. They were required to redo all of their financials for 2023. They actually are/were not even allowed to sell fertilizer at said time.

learningcurve2020

learningcurve2020 2 minutes ago

Hey, they’re the lawyers writing this stuff. Why suddenly “Prospective” and why not “Clinical”?

LandPro

LandPro 2 minutes ago

Wouldnt be surprised to see this trading in the trips without any real substance to hold its current value. Already half its value lost just since last month. Trade it or watch profits disappear.

Buckey

Buckey 3 minutes ago

I lost a $20 bet on that one

But irregardless has since been added to the dictionary a

Nebraskan

Nebraskan 3 minutes ago

Jim is the best, most knowledgeable, representative NioCorp could have representing the company. ALL compensated lobbyists get paid in one form or another and there is a record of that payment someplace on both the state and federal level.

Drugdoctor

Drugdoctor 3 minutes ago

Says the 🤡 that missed the 100,000% rally and said sell. Why would anyone respond to a non trader who posts fake info?

janice shell

janice shell 3 minutes ago

And that is not very long.

vlispxpert

vlispxpert 3 minutes ago

CGC just remember, we are soooo early

jay_tee

jay_tee 3 minutes ago

I mean Filter posted in bold faced red letters like that's supposed to make it true. Honestly nothing matters because ALL of our RNVA accounts are worthless. No one can refute that. No matter what Wannabe Boosie Badazz posts his account is worthless also....

JJ8

JJ8 3 minutes ago

I agree with you in most of what you said.

All the innovative hard work has been done by the pioneer leader and his hard working team.

I like the Chinese people and their culture. They have patience and can focus in valuable imitative highly valued fashionable products

RobotDroid

RobotDroid 4 minutes ago

Lone Clone

Lone Clone 4 minutes ago

Prime’s Central Trend Continues to Deliver Strong Grades and Continuity, Defining a 400-metre High-Grade Shoot at Noche Buena Mineralization Remains

https://www.globenewswire.com/news-release/2025/01/30/3017816/0/en/Prime-s-Central-Trend-Continues-to-Deliver-Strong-Grades-and-Continui

100lbStriper

100lbStriper 4 minutes ago

lol!!! i've been going back in forth with myself when watching this guy as to how much of it is actually acting....... i do know he can play a guitar, and learns quite quickly i might add. but the guy with a drink in his hands at all times really makes me crack up...

Jahvik

Jahvik 4 minutes ago

https://www.xchain.cz/

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions